Span Divergent Q1 Results: Consolidated loss widens to ₹118.82 lakhs

2 min read     Updated on 11 Aug 2026, 08:14 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Span Divergent Ltd posted a consolidated net loss of ₹118.82 lakhs in Q1FY27, up from ₹17.01 lakhs in Q1FY26, due to weak cashew processing revenues. Standalone net loss was ₹4.22 lakhs. Subsidiaries continue to face substantial accumulated losses, with Biospan Contamination Control Solutions showing negative net worth.

powered bylight_fuzz_icon
48005087

*this image is generated using AI for illustrative purposes only.

Span Divergent reported a consolidated net loss of ₹118.82 lakhs for the first quarter ended June 30, 2026 (Q1FY27), a significant deterioration from the consolidated net loss of ₹17.01 lakhs recorded in the corresponding period of FY26. The widening loss was primarily attributed to severe underperformance in its core cashew processing segment, where revenue plummeted while operating losses expanded. Standalone operations also turned negative, reporting a net loss of ₹4.22 lakhs compared to a net profit of ₹41.67 lakhs in Q1FY26.

The Board of Directors approved the unaudited financial results on August 11, 2026. The figures were reviewed by the Audit Committee and subjected to a limited review by the statutory auditors, Y. B. Desai & Associates, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The financial statements have been prepared in accordance with Indian Accounting Standards (Ind AS) notified under Section 133 of the Companies Act, 2013.

Consolidated Financial Performance

Consolidated revenue from operations dropped sharply to ₹102.55 lakhs in Q1FY27, down from ₹126.61 lakhs in Q1FY26. This decline was driven by the cashew processing segment, which generated only ₹35.41 lakhs in revenue, a fraction of the ₹379.56 lakhs recorded in the preceding quarter (Q4FY26). The trading segment contributed ₹67.14 lakhs, down from ₹111.34 lakhs in the year-ago quarter.

Total expenses stood at ₹244.77 lakhs, leading to an operating loss before interest and tax of ₹114.57 lakhs. Finance costs increased to ₹13.67 lakhs from ₹11.92 lakhs in Q1FY26. Deferred tax expense added ₹4.25 lakhs to the bottom line pressure.

Metric Q1FY27 (₹ Lakhs) Q1FY26 (₹ Lakhs) Change
Revenue from Operations 102.55 126.61 -19.0%
Total Expenses 244.77 212.67 +15.1%
Profit/(Loss) Before Tax (114.57) (14.46) Widened
Net Profit/(Loss) (118.82) (17.01) Widened

Standalone Results and Segment Issues

On a standalone basis, total income fell to ₹30.83 lakhs from ₹64.93 lakhs in Q1FY26. Other operating income, comprising interest on fluctuating capital provided to LLP subsidiaries and management fees, declined to ₹13.45 lakhs from ₹38.45 lakhs. Total expenses rose to ₹46.56 lakhs from ₹41.19 lakhs, largely due to higher other expenses of ₹14.00 lakhs compared to ₹7.99 lakhs in the prior year.

The company disclosed significant challenges within its subsidiaries. Aranya Consulting and Biotech LLP had accumulated losses of ₹1,494 lakhs as of March 31, 2026. Biospan Contamination Control Solutions Pvt. Ltd reported accumulated losses of ₹742 lakhs as of June 30, 2026, with total liabilities exceeding total assets by ₹752 lakhs. Despite these deficits, management continues to prepare financial results on a going concern basis, citing plans for product introductions and potential business tie-ups to revive operations.

What the Numbers Show

The divergence between standalone and consolidated performance highlights the heavy drag from subsidiary operations. While the standalone entity managed to contain its loss to ₹4.22 lakhs through lower income but controlled core expenses, the consolidated group absorbed massive operating losses from the cashew processing unit. The cashew segment incurred a pre-tax loss of ₹81.93 lakhs despite generating ₹35.41 lakhs in revenue, indicating a fundamental mismatch between current scale and fixed cost structures. Furthermore, the unutilized proceeds of ₹127.04 lakhs from the March 2026 preferential issue remain available for stated objects, including raw cashew nut inventory procurement, suggesting management intends to ramp up working capital to address these operational gaps.

Historical Stock Returns for Span Divergent

1 Day5 Days1 Month6 Months1 Year5 Years
-1.15%+10.82%-7.00%-4.09%+67.92%+152.07%

How does management plan to utilize the ₹127.04 lakhs in unutilized preferential issue proceeds to specifically address the cashew segment's working capital deficit and reverse its revenue decline?

Given that Biospan Contamination Control Solutions has liabilities exceeding assets by ₹752 lakhs, what is the timeline and specific criteria for evaluating potential business tie-ups or restructuring to ensure viability?

What operational restructuring measures are being considered for the cashew processing unit to align fixed costs with current revenue levels and stop the widening operating losses?

Span Divergent Ltd receives adverse arbitration award of INR 24,55,614

1 min read     Updated on 06 Jul 2026, 06:43 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Span Divergent Ltd received an adverse arbitration award of INR 24,55,614 plus interest from the Gujarat High Court Arbitration Centre regarding an employment dispute. The company plans to challenge the award legally, noting it has not attained finality. The disclosure was made following an internal compliance review.

powered bylight_fuzz_icon
44889178

*this image is generated using AI for illustrative purposes only.

Span Divergent Ltd has received an adverse arbitration award of INR 24,55,614 along with simple interest from the Gujarat High Court Arbitration Centre. The award, dated July 02, 2026, was issued in a dispute involving Pareshkumar Prabhudas Patel as the claimant and Span Divergent Ltd, Aranya Agri Biotech LLP, and Viral Pradipkumar Desai as respondents. The matter relates to an employment agreement with the claimant.

The company disclosed this information to the Bombay Stock Exchange on July 06, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was delayed inadvertently during an internal compliance review. Span Divergent Ltd confirmed there was no intention to withhold material information and stated it has strengthened its internal compliance mechanisms.

According to the award, the company is liable to pay the principal amount of INR 24,55,614 plus simple interest at 12% per annum from August 09, 2019, to July 02, 2026. The company noted that based on legal advice, it is considering appropriate legal remedies available under applicable laws.

Legal Recourse and Financial Impact

Span Divergent Ltd stated that the arbitral award is subject to further legal recourse and may not have attained finality. The company proposes to challenge the award before a competent court or forum. Consequently, the ultimate financial impact will depend on the outcome of these legal proceedings.

Particulars Information
Name of the authority The Gujarat High Court Arbitration Centre, Sola, Ahmedabad
Date of award 02-07-2026
Amount awarded INR 24,55,614
Interest rate 12% per annum (simple interest)
Interest period 09 August 2019 to 02 July 2026
Nature of dispute Employment agreement

The company acknowledged that the award may have an adverse financial impact to the extent of the awarded amount and applicable interest. However, it emphasized that the situation remains contingent upon the final legal outcome.

Historical Stock Returns for Span Divergent

1 Day5 Days1 Month6 Months1 Year5 Years
-1.15%+10.82%-7.00%-4.09%+67.92%+152.07%

What is the likelihood of Span Divergent Ltd successfully overturning the arbitral award in court?

How will the potential payout of INR 2.45 million plus interest affect the company's short-term liquidity?

Will this adverse award trigger any review of the company's existing employment contracts and compliance frameworks?

More News on Span Divergent

1 Year Returns:+67.92%